BridgeMD
New treatment option for Vestibular Schwannoma
Official title Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
ClinicalTrials.gov ID: NCT06112509
What this study is testing
- What it's testing
- The purpose of this study is to evaluate the vestibular effects of gamma-knife radiosurgery, as part of the treatment of vestibular schwannoma.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90. Healthy volunteers may be eligible.
You may be able to join if
- Men and women aged 18 to 90 included
- Subject who benefited from gamma-knife radiosurgery as part of the treatment of vestibular schwannoma
- Non-opposition of the subject to participate in the study
- Affiliation to a French social security scheme or beneficiary of such a scheme
You likely can't join if
- Subject with another vestibular pathology
- Subject who did not benefit from a vestibular assessment before treatment with gamma-knife radiosurgery
- Legal incapacity or limited legal capacity
- Subject unlikely to cooperate in the study and/or weak cooperation anticipated by the investigator
- Subject without health insurance
- Subject being in the period of exclusion from another study or provided for by the "national volunteer file".
The study team makes the final eligibility decision.
Where it's taking place
- Besançon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Besançon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.